| Name | Title | Contact Details |
|---|
Changing lives with next generation peptide therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Our therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of disease. Kyverna is venture-backed and located in the San Francisco East Bay.
Divergence is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Welcome to Vivacelle Bio Inc.
Pioneering the next generation of non-viral gene therapy - by tackling more diseases, more precisely and in a more personalized way.